Published by: Cell Press
http://www.cell.com/molecular-therapy-family/methods/latest-content
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Molecular Biology | 47 | 60 | 114 | 24 |
| Biology and Biochemistry | 147 | 226 | 300 | 33 |
| Medicine | 549 | 194 | 236 | 33 |
The discussions in Molecular therapy. Methods & clinical development mainly cover the fields of Genetic enhancement, Cell biology, Viral vector, Transduction (genetics) and Cancer research. The concepts on Genetic enhancement presented in the journal can also apply to other research fields, including Vector (molecular biology), Adeno-associated virus, Transgene and Virus. Discussions in it are anchored in the subject of Transgene and the similar topic of Molecular biology.
The Virus study which was featured in Molecular therapy. Methods & clinical development aims to expound on the research in Immunology. It focuses on Cell biology but the discussions also offer insight into other areas such as Cell, Cell culture, Transfection, Induced pluripotent stem cell and In vivo. The work on Viral vector tackled in Molecular therapy. Methods & clinical development brings together disciplines like Haematopoiesis and Virology.
Molecular therapy. Methods & clinical development focuses on Virology but sometimes tackles the closely related topic of Antibody which is concerned with Immune system. Molecular therapy. Methods & clinical development addresses concerns in Transduction (genetics) which are intertwined with other disciplines, such as Tropism, Green fluorescent protein, Gene delivery and Capsid. The featured Cancer research studies mainly concentrate on Stem cell but also cover areas of interest in Transplantation.
The journal articles aim to foster the development of research in Genetic enhancement, Cell biology, Immunology, Transgene and Viral vector. The journal publications explore issues in Genetic enhancement which can be linked to other research areas like Adeno-associated virus, Haematopoiesis, Stem cell and Cancer research. The Viral vector studies discussed in the journal papers incorporate research from disciplines like
Molecular therapy. Methods & clinical development mostly deals with topics like Genetic enhancement, Cell biology, Cancer research, Viral vector and Transduction (genetics). While it focused on Genetic enhancement, it was also able to explore topics like Progenitor cell and Vector (molecular biology), Adeno-associated virus. The research on Cell biology tackled can also make contributions to studies in the areas of Transgene, Phenotype, Genome editing, Chimeric antigen receptor and Electroporation.
Concepts in Stem cell, as well as related topics in Bone marrow, are covered in the Cancer research research presented in it. Molecular therapy. Methods & clinical development dives deep in exploring the relationship between the study of Viral vector and Immunology. It explores issues in Transduction (genetics) which can be linked to other research areas like Tropism and CD8.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Molecular therapy. Methods & clinical development (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Molecular therapy. Methods & clinical development (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 4.08% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.68% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.83% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.21% of all publications and 46.28% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Narjes Saheb Sharif-Askari;Fatemeh Saheb Sharif-Askari;Mashael Alabed;Mohamed Hani Temsah
(2020)Ana Lemos de Matos;Lina S. Franco;Grant McFadden
(2020)Andreas L. Gimpel;Andreas L. Gimpel;Georgios Katsikis;Sha Sha;Andrew John Maloney
(2021)Vesa Anttila;Antti Saraste;Juhani Knuuti;Pekka Jaakkola
(2020)Neil G. Rumachik;Stacy A. Malaker;Nicole Poweleit;Lucy H. Maynard
(2020)Emmanuelle Berger;Pascal Colosetti;Audrey Jalabert;Emmanuelle Meugnier
(2020)Jesse H. Erasmus;Jesse H. Erasmus;Jacob Archer;Jacob Archer;Jasmine Fuerte-Stone;Amit P. Khandhar
(2020)Tomohiro Umezu;Masakatsu Takanashi;Yoshiki Murakami;Shin-ichiro Ohno
(2021)Daelyn Y. Richards;Shelley R. Winn;Sandra Dudley;Sean Nygaard
(2020)For those interested in healthcare careers related to Medicine in the USA, there are several online degree options and career pathways worth considering. For individuals without a nursing background, exploring online absn programs for non nurses can provide an accelerated route to becoming a registered nurse.
Once you become an RN, advancing your education through some of the shortest rn to bsn program options available online can be an efficient way to boost your credentials and open up more opportunities.
For those considering advanced practice roles, becoming a nurse practitioner is a popular goal. Understanding how many years to become a nurse practitioner is crucial for planning your educational timeline and career progression in this field.
Specializing further as a psychiatric mental health nurse practitioner comes with its own rewards and challenges, including salary variations by location. Knowing the details about pmhnp salary by state can help inform your career decisions based on where you want to practice.
